MTOR and diabetic kidney disease: The mammalian target of rapamycin (mTOR) signaling pathway is an important element of autophagy, and an animal model showed that rapamycin has beneficial effects on the histopathological changes in rats with DKD by inhibiting the mTOR signaling pathway, but it has some side effects, including immunosuppression and renal toxicity [243,244].